4.4 Article

Dexmedetomidine pretreatment alleviates cerebral ischemia/reperfusion injury by inhibiting neuroinflammation through the JAK2/STAT3 pathway

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Biochemistry & Molecular Biology

Function and proteolytic generation of the soluble interleukin-6 receptor in health and disease

Tim Schumertl et al.

Summary: Interleukin-6 (IL-6) is a pleiotropic cytokine involved in various physiological and pathophysiological functions. It can signal through different pathways, with trans-signaling playing a crucial role in its pro-inflammatory properties. The soluble form of the IL-6 receptor (sIL-6R) is generated by different mechanisms, including proteolysis. Attempts to selectively block IL-6 trans-signaling are being made in pre-clinical animal models and clinical studies for inflammatory bowel disease.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2022)

Review Anesthesiology

Dexmedetomidine as an Analgesic Agent with Neuroprotective Properties: Experimental and Clinical Aspects

Hooman Bozorgi et al.

Summary: Dexmedetomidine is a sedative agent with neuroprotective properties, improving outcomes for ICU patients and serving as a non-opioid analgesic therapy. Despite its benefits, clinicians must be aware of potential adverse effects like hypotension and bradycardia.

JOURNAL OF PAIN & PALLIATIVE CARE PHARMACOTHERAPY (2021)

Article Neurosciences

Dexmedetomidine inhibits apoptosis of astrocytes induced by oxygen-glucose deprivation via targeting JAK/STAT3 signal pathway

Pengjiu Feng et al.

Summary: This study revealed that dexmedetomidine protects astrocytes against apoptosis by inhibiting the JAK/STAT signal pathway and downregulating JMJD3 expression in vitro.

BRAIN RESEARCH (2021)

Review Neurosciences

The potential role of dexmedetomidine on neuroprotection and its possible mechanisms: Evidence from in vitro and in vivo studies

Kantarakorn Unchiti et al.

Summary: Dexmedetomidine, a selective alpha 2-adrenoceptor agonist, has shown neuroprotective effects in various models of neuronal injury. Its mechanisms of neuroprotection involve neurotransmitter regulation, inflammatory response, oxidative stress, and other cell signalling pathways. Dexmedetomidine holds promise as a novel neuroprotective agent for a wide range of neurological disorders.

EUROPEAN JOURNAL OF NEUROSCIENCE (2021)

Review Immunology

The involvement of JAK/STAT signaling pathway in the treatment of Parkinson's disease

Naser-Aldin Lashgari et al.

Summary: Parkinson's disease is a neurodegenerative disorder characterized by the aggregation of alpha-synuclein in neurons, with evidence suggesting that inflammation can lead to neuroinflammation. The JAK/STAT signaling pathway may play a key role in PD progression through increased inflammation-associated gene transcription. Interferon gamma and interleukin-6 are potent activators of this pathway in PD, and research on JAK inhibitors shows promise for managing a variety of diseases, including PD.

JOURNAL OF NEUROIMMUNOLOGY (2021)

Review Immunology

Understanding the Connection Between Common Stroke Comorbidities, Their Associated Inflammation, and the Course of the Cerebral Ischemia/Reperfusion Cascade

Lukasz Przykaza

Summary: Common concomitant stroke risk factors such as hypertension, diabetes, and hyperlipidemia exacerbate inflammatory processes during cerebral ischemia/reperfusion, leading to dysfunction of neurovascular units. In-depth basic research on these factors is crucial for the success of future neuroprotection, vasculoprotection, and immunomodulation therapies in stroke.

FRONTIERS IN IMMUNOLOGY (2021)

Article Pharmacology & Pharmacy

The effect of dexmedetomidine on liver injury secondary to lower extremity ischemia-reperfusion in a diabetic rat model

Seyfi Kartal et al.

Summary: The study evaluated the hepatic protective effects of dexmedetomidine in diabetic rats with lower extremity ischemia-reperfusion, showing improvement in biochemical markers and histopathological parameters in liver tissue, and a decrease in liver damage after ischemia-reperfusion.

CLINICAL AND EXPERIMENTAL HYPERTENSION (2021)

Article Neurosciences

The bidirectional role of the JAK2/STAT3 signaling pathway and related mechanisms in cerebral ischemia-reperfusion injury

Yi Zhong et al.

Summary: The JAK2/STAT3 signaling pathway plays a crucial role in ischemic stroke by regulating inflammatory response, apoptosis, oxidative stress, and angiogenesis.

EXPERIMENTAL NEUROLOGY (2021)

Article Nanoscience & Nanotechnology

Would Colloidal Gold Nanocarriers Present An Effective Diagnosis Or Treatment For Ischemic Stroke?

Hamed Amani et al.

INTERNATIONAL JOURNAL OF NANOMEDICINE (2019)

Review Pharmacology & Pharmacy

Targeting vascular inflammation in ischemic stroke: Recent developments on novel immunomodulatory approaches

Shashank Shekhar et al.

EUROPEAN JOURNAL OF PHARMACOLOGY (2018)

Review Pharmacology & Pharmacy

Advances in stroke pharmacology

Zhenhua Zhou et al.

PHARMACOLOGY & THERAPEUTICS (2018)

Review Biochemistry & Molecular Biology

The molecular details of cytokine signaling via the JAK/STAT pathway

Rhiannon Morris et al.

PROTEIN SCIENCE (2018)

Review Immunology

The IL-6/gp130/STAT3 signaling axis: recent advances towards specific inhibition

Christoph Garbers et al.

CURRENT OPINION IN IMMUNOLOGY (2015)

Article Biochemistry & Molecular Biology

JAK2 and STAT3 activation contributes to neuronal damage following transient focal cerebral ischemia

Irawan Satriotomo et al.

JOURNAL OF NEUROCHEMISTRY (2006)